Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as

Podcasts:

 How to Sustain Effective Continuous Improvement in Your Organisation | File Type: audio/mpeg | Duration: Unknown

Lean principles drive cost reduction, improve efficiency and increase ROI. In this podcast, Elisabeth Goodman, former Business Operations Consultant, GlaxoSmithKline and Owner of RiverRhee Consulting, speaks to Andrea Charles at Pharma IQ, about the unique challenges to sustaining

 Challenges and Opportunities in the Use of Biomarkers in Early Phase Trials | File Type: audio/mpeg | Duration: Unknown

In this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development, a t which points they should be utilised and how. Jenkins draws attention to the

 What are the Requirements for Establishing a Data Network Collaboration? | File Type: audio/mpeg | Duration: Unknown

In this interview Jos van den Heuvel, Director of External Manufacturing at Janssen Pharmaceutica NV, Johnson & Johnson, speaks to Rebecca Maschke from Pharma IQ, about supplier integration and the advantages of establishing a data network collaboration.

 The Calm Before the Storm: Preparing for the EU Pharma Package | File Type: audio/mpeg | Duration: Unknown

Jim Thomson, Chair of the European Alliance for Access to Safer Medicines (EAASM), discusses the implications of the EU Pharma package with Helen Winsor from Pharma IQ. Thomson explains how pharmaceutical packaging and anti-counterfeiting measures have changed over the past five years.

 How to Address the IP Issues Specifically Associated with Polymorphic Forms | File Type: audio/mpeg | Duration: Unknown

It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and

 What is the Goal of the Budni-Partner-Pharmacies Project? | File Type: audio/mpeg | Duration: Unknown

In this German-speaking interview, Jens Apermann, CEO of Iwan Budnikowsky Marketing GmbH, gives insight into his company’s marketing and selling of non-prescription pharmaceutical products outside the traditional German pharmacy setting.

 Adaptive Design, Often Maligned | File Type: audio/mpeg | Duration: Unknown

When carried out well, adaptive trials not only provide evidence of safety and efficacy more quickly, but also allow you to assess that evidence and get answers earlier. In this interview John Johnson, Senior Biostatistician at Cato Research, speaks to Andrea Charles from

 Meet Your Goals: Choose the Right Partner and Cut Costs | File Type: audio/mpeg | Duration: Unknown

Patrice Talaga, Director of Chemistry Outsourcing at UCB, shares his experience of early alliance partnerships between academia and pharmaceutical companies, in this exclusive interview with Helen Winsor from Pharma IQ.  Talaga outlines the main challenges in global discovery

 Ensuring In-House Audit Programmes are Strategically Focused through Implementing Risk Models | File Type: audio/mpeg | Duration: Unknown

20% of all clinical trials are now subject to regulatory audits! With inspectors’ expectations continually evolving and an increasing number of regulatory warnings, relating to record keeping and informed consent, it is more important than ever to comply with GCP and be

 Improving Pharmaceuticals Through Co-Crystals | File Type: audio/mpeg | Duration: Unknown

In this podcast Dr. Nair Rodriguez-Hornedo, Professor, Department of Pharmaceutical Sciences at the University of Michigan, s peaks to Andrea Charles from Pharma IQ, about h ow can we improve pharmaceuticals through co-crystals and overcoming the various challenges of co-crystal

 Was sind die Herausforderungen auf der letzten Meile zum Patienten? | File Type: audio/mpeg | Duration: Unknown

In diesem Interview spricht Walter Heider, Director Commercial Department und Business Development bei der Sanofi-Aventis GmbH, über qualifizierte und zukunftsfähige Transportmöglichkeiten, und Herausforderungen in der Pharma Distribution.

 Integration and Interoperability in the Laboratory: Will You Find Your Match? | File Type: audio/mpeg | Duration: Unknown

You may have some or all of your informatics systems in place, and they may work well, but chances are good they do not work well together. Perhaps nowhere is this more noticeable than after mergers, when two or more firms need to be able to access and join previously separate data on

 Conducting Effective Clinical Evaluations for Medical Devices | File Type: audio/mpeg | Duration: Unknown

In this podcast Sven Knoke, Quality and Regulatory Affairs Manager at Siemens, speaks to Andrea Charles from Pharma IQ, about conducting effective clinical evaluations for medical devices and achieving market access by executing thorough clinical literature reviews.  

 3rd Party Integration: Mitigating Risks | File Type: audio/mpeg | Duration: Unknown

In this interview Béatrice Serckx, Associate Director, Drug Production Industrial Strategy and CMO Management, UCB Pharma, speaks to Andrea Charles from Pharma IQ, about the hurdles to successful supplier integration and how to measure the success of your mitigation plan.

 Corporate Whistleblowing in Pharma | File Type: audio/mpeg | Duration: Unknown

Shaul Brazil, a lawyer at BCL Burton Copeland, represented Robert John Dougall, the first executive to be prosecuted by the Serious Fraud Office (SFO) for overseas corruption.  The case arose out of corrupt practices in the supply of orthopaedic products by Mr Dougall’s

Comments

Login or signup comment.